Gilead Faces Fights Over Hepatitis C and H.I.V. Drugs by ANDREW POLLACK

By ANDREW POLLACK

The company may face legal action in Massachusetts unless it drops prices for its hepatitis C drugs. In California, it is being sued over patents for an H.I.V. treatment.

Published: January 28, 2016 at 12:00AM

from NYT Business Day http://ift.tt/1NBVWv0

from WordPress http://ift.tt/1SL4BDb
via Hadi Aboukhater